and enjoy FREE SHIPPING
Vital treatment for Acute Promyelocytic Leukemia (APL)
FDA-approved active ingredient (Tretinoin)
Typically starts showing effect in 1-3 weeks
Low risk of recurrence with proper treatment
Dr. Akansha is a licensed Clinical Pharmacologist with extensive expertise in pharmacovigilance, prescription analysis, drug information, and safety. She's a dedicated educator and avid learner. Dr. Akansha also reviews medical content on GoodRxMedicine, ensuring accurate pharmaceutical information is accessible to all.
Julian, an MBA in Pharmaceutical Management, brings a dynamic blend of expertise and impact with his contributions at GoodRxMedicine. His dedication and innovative spirit continue to shape a brighter future in pharmaceutical management.
CA Atra is an anticancer medication that includes Tretinoin, a vitamin A derivative. It is primarily used for treating Acute Promyelocytic Leukemia (APL), a rare type of Blood Cancer. It works by stimulating the differentiation of immature blood cells into mature ones, limiting Cancer cell growth.
The medication is frequently used as part of combination therapy to increase treatment efficacy and patient outcomes in controlling this severe blood condition. Jenome Biophar Pvt. Ltd manufactures it.
CA Atra 10 capsules can be used under the following circumstances:
Tretinoin, a Vitamin A derivative, is a potent retinoid therapy for Acute Promyelocytic Leukemia (APL). In APL, abnormal white blood cells known as Promyelocytes accumulate in the bone marrow, blocking normal blood cell synthesis.
This is caused by a genetic abnormality that prevents immature cells from growing into healthy white blood cells. Tretinoin targets and breaks down this unusual protein, allowing Leukemia cells to develop into normal white blood cells.
This mechanism helps the body naturally eliminate Cancer cells.
Tretinoin serves the following benefits for APL:
Always take the medication as directed by your doctor to get the most out of it. Here are common usage guidelines:
When used as directed, these capsules are generally well-tolerated. However, some mild side effects may occur, including:
These side effects often do not require medical aid and vanish as your body adjusts to the medication. However, seek medical advice promptly if you experience any persistent or troublesome side effects.
CA Atra 10, like other medications, may interact with other prescription and over-the-counter medications, certain foods, and health conditions.
The capsule may interact with the following medicines, increasing the risk of potential side effects:
This is not the complete list of interacting medicines. Reach out to your doctor for further assistance.
CA Atra capsules may interact with certain health conditions. Here are some significant disease interactions to consider:
Always consult a healthcare expert before beginning the therapy, mainly if you have any underlying health issues.
While no particular dietary interactions have been identified that would impair the efficacy of CA Atra, it is essential to consider the following:
When using CA Atra capsules to treat APL, take the following precautions:
Always follow your healthcare provider's recommendations for safe use.
Following are some potential reasons that make GoodRxMedicine a compelling choice for purchasing medicines:
Yes. Atra may affect fertility, especially when taken with chemotherapy. Men may have temporary or permanent sperm count declines, and women may experience irregular menstruation cycles. Fertility preservation alternatives should be considered before therapy.
Hypercalcemia (high calcium levels in the blood) is a rare adverse effect of Atra that can develop when combined with certain antifungal medications, such as Posaconazole. Other unusual problems may include differentiation syndrome, marked by fever, respiratory distress, and weight increase.
It is best to consult your doctor before undertaking cosmetic operations while using the capsule. Atra could worsen skin sensitivity and inflammation, which can impede recovery following cosmetic procedures.
Atra is usually given for 30 days during the induction phase of treatment for APL. Depending on the patient's reaction and treatment strategy, it may be used as part of consolidation or maintenance therapy.
Yes. AML is treatable, especially if diagnosed early and treated rapidly, which may include chemotherapy and stem cell transplants. However, the prognosis varies depending on age, genetic abnormalities, and overall health, making certain patients more difficult to treat successfully.
inside review file